Thymosin Alpha-1 (10mg)
Thymosin Alpha-1 is a 28-amino-acid peptide originally isolated from the thymus gland, investigated extensively in immunology research for its role in T-cell maturation, immune modulation, and adjunctive use in infectious and oncology research.
About Thymosin Alpha-1
Thymosin Alpha-1 (Tα1) is a 28-amino-acid acetylated peptide originally isolated from bovine thymus fraction 5 in the 1970s. It is one of the most extensively studied thymic peptides, with over four decades of research literature spanning immunology, infectious disease research, and oncology adjunctive research. It is approved as a therapeutic agent in several countries.
Mechanism in Research Literature
Research on Thymosin Alpha-1 has documented:
- Enhancement of T-cell maturation and function
- Modulation of dendritic cell antigen presentation
- Effects on natural killer (NK) cell activity
- Balanced effect on Th1/Th2 cytokine production
- Modulation of TLR (toll-like receptor) signaling
- Immunomodulatory rather than purely immunostimulatory profile in research
Research Context
Thymosin Alpha-1 has been investigated in studies exploring:
- T-cell biology and adaptive immune function
- Chronic viral infection research (hepatitis B, hepatitis C)
- Oncology adjunctive research
- Immune reconstitution in immunocompromised models
- Sepsis and severe infection research
- Combination immune research with other modulating compounds
Related Research Peptides
Thymosin Alpha-1 appears in literature alongside other immune-modulating research peptides (LL-37, KPV, VIP) and broader immune research compounds.
